- Home
- FNWB vs ZURA Comparison
FNWB vs ZURA Comparison
Compare FNWB & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNWB
- ZURA
- Stock Information
- Founded
- FNWB 1923
- ZURA 2022
- Country
- FNWB United States
- ZURA United States
- Employees
- FNWB N/A
- ZURA N/A
- Industry
- FNWB Banks
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FNWB Finance
- ZURA Health Care
- Exchange
- FNWB Nasdaq
- ZURA Nasdaq
- Market Cap
- FNWB 79.5M
- ZURA 69.9M
- IPO Year
- FNWB 2015
- ZURA N/A
- Fundamental
- Price
- FNWB $8.18
- ZURA $1.66
- Analyst Decision
- FNWB Hold
- ZURA Strong Buy
- Analyst Count
- FNWB 1
- ZURA 9
- Target Price
- FNWB $12.00
- ZURA $14.00
- AVG Volume (30 Days)
- FNWB 24.4K
- ZURA 369.7K
- Earning Date
- FNWB 07-24-2025
- ZURA 08-14-2025
- Dividend Yield
- FNWB 3.42%
- ZURA N/A
- EPS Growth
- FNWB N/A
- ZURA N/A
- EPS
- FNWB N/A
- ZURA N/A
- Revenue
- FNWB $48,874,000.00
- ZURA N/A
- Revenue This Year
- FNWB $35.06
- ZURA N/A
- Revenue Next Year
- FNWB $13.06
- ZURA N/A
- P/E Ratio
- FNWB N/A
- ZURA N/A
- Revenue Growth
- FNWB N/A
- ZURA N/A
- 52 Week Low
- FNWB $6.05
- ZURA $0.97
- 52 Week High
- FNWB $12.10
- ZURA $5.07
- Technical
- Relative Strength Index (RSI)
- FNWB 58.66
- ZURA 58.91
- Support Level
- FNWB $7.74
- ZURA $1.44
- Resistance Level
- FNWB $8.20
- ZURA $1.52
- Average True Range (ATR)
- FNWB 0.26
- ZURA 0.13
- MACD
- FNWB 0.05
- ZURA 0.00
- Stochastic Oscillator
- FNWB 95.04
- ZURA 76.92
About FNWB First Northwest Bancorp
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.